Haemonetics Corp. (hae 2.5 06/01/29)
13F holders, Q2 2025 (June 30)6holders
$0.99avg. 13F price*
At the end of Q2 2025, 6 institutions reported holding Haemonetics Corp. (hae 2.5 06/01/29) in their 13F filings. The largest holders were New York State Common Retirement Fund ($4.8M), Income Research & Management ($3.0M) and Ameritas Investment Partners, Inc. ($1.9M).
- Company
- Haemonetics Corp. (hae 2.5 06/01/29)
- CUSIP
- 405024AD2
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $10.3M |
| Exits | 0 | $0 |
Ownership 6 holders
| New York State Common Retirement Fund | 0.01% | New | 4,880,000 | $4.8M |
| Income Research & Management | 0.79% | New | 2,985,000 | $3.0M |
| Ameritas Investment Partners, Inc. | 0.06% | New | 1,930,000 | $1.9M |
| Bank of New York Mellon Corp | 0.00% | New | 500,000 | $499K |
| Cetera Investment Advisers | 0.00% | New | 35,000 | $35K |
| Choreo, LLC | 0.00% | New | 28,000 | $28K |
"% of holder's portfolio" is HAEMONETICS CORP (HAE 2.5 06/01/29)'s weight in each manager's 13F, not the share of Haemonetics Corp. (hae 2.5 06/01/29) the manager owns.